Literature DB >> 29018274

Current and emerging therapeutic targets for IBD.

Markus Neurath.   

Abstract

This corrects the article DOI: 10.1038/nrgastro.2016.208.

Year:  2017        PMID: 29018274     DOI: 10.1038/nrgastro.2017.138

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  1 in total

Review 1.  Current and emerging therapeutic targets for IBD.

Authors:  Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-01       Impact factor: 46.802

  1 in total
  24 in total

1.  Hookworm-Derived Metabolites Suppress Pathology in a Mouse Model of Colitis and Inhibit Secretion of Key Inflammatory Cytokines in Primary Human Leukocytes.

Authors:  Phurpa Wangchuk; Catherine Shepherd; Constantin Constantinoiu; Rachael Y M Ryan; Konstantinos A Kouremenos; Luke Becker; Linda Jones; Geraldine Buitrago; Paul Giacomin; David Wilson; Norelle Daly; Malcolm J McConville; John J Miles; Alex Loukas
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

2.  Simulation and visualization of multiple KEGG pathways using BioNSi.

Authors:  Adva Yeheskel; Adam Reiter; Metsada Pasmanik-Chor; Amir Rubinstein
Journal:  F1000Res       Date:  2017-12-11

3.  Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis.

Authors:  Nicole Dmochowska; William Tieu; Marianne D Keller; Hannah R Wardill; Chris Mavrangelos; Melissa A Campaniello; Prab Takhar; Patrick A Hughes
Journal:  J Nucl Med       Date:  2018-11-09       Impact factor: 10.057

4.  Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis.

Authors:  Youbo Zhang; Tingting Yan; Dongxue Sun; Cen Xie; Tianxia Wang; Xiaoyan Liu; Jing Wang; Qiong Wang; Yuhong Luo; Ping Wang; Tomoki Yagai; Kristopher W Krausz; Xiuwei Yang; Frank J Gonzalez
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

5.  Delivery of therapeutic carbon monoxide by gas-entrapping materials.

Authors:  James D Byrne; David Gallo; Hannah Boyce; Sarah L Becker; Kristi M Kezar; Alicia T Cotoia; Vivian R Feig; Aaron Lopes; Eva Csizmadia; Maria Serena Longhi; Jung Seung Lee; Hyunjoon Kim; Adam J Wentworth; Sidharth Shankar; Ghee Rye Lee; Jianling Bi; Emily Witt; Keiko Ishida; Alison Hayward; Johannes L P Kuosmanen; Josh Jenkins; Jacob Wainer; Aya Aragon; Kaitlyn Wong; Christoph Steiger; William R Jeck; Dustin E Bosch; Mitchell C Coleman; Douglas R Spitz; Michael Tift; Robert Langer; Leo E Otterbein; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2022-06-29       Impact factor: 19.319

Review 6.  Filgotinib: A Clinical Pharmacology Review.

Authors:  Florence Namour; Kacey Anderson; Cara Nelson; Chantal Tasset
Journal:  Clin Pharmacokinet       Date:  2022-05-31       Impact factor: 5.577

Review 7.  IL-36 cytokines and gut immunity.

Authors:  Vu L Ngo; Michal Kuczma; Estera Maxim; Timothy L Denning
Journal:  Immunology       Date:  2021-02-24       Impact factor: 7.215

8.  GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis in the treatment of inflammatory bowel disease.

Authors:  Qijiang Mao; Haoqi Pan; Yiyin Zhang; Yi Zhang; Qiuwen Zhu; Yi Hong; Zhengze Huang; Yang Li; Xu Feng; Yifeng Fang; WenChao Chen; Pengfei Chen; Bo Shen; Hongwei Ouyang; Yuelong Liang
Journal:  Bioact Mater       Date:  2022-04-21

Review 9.  Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases.

Authors:  Irene Marafini; Giovanni Monteleone
Journal:  Biologics       Date:  2020-06-15

10.  Protective Effect of Saffron in Mouse Colitis Models Through Immune Modulation.

Authors:  Aida Habtezion; Hassan Ashktorab; Gulshan Singh; Yeneneh Haileselassie; Allison Ruoheng Ji; Holden Terry Maecker; Sidhartha R Sinha; Hassan Brim
Journal:  Dig Dis Sci       Date:  2021-07-17       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.